FDA Adverse Event Malfunction Summary report: N

UNICEL® DXH 800 COULTER® CELLULAR ANALYSIS SYSTEM

MDR report key: 2233732 · Received September 3, 2011

Report

Report Number
1061932-2011-01360
Event Type
Malfunction
Date Received
September 3, 2011
Date of Event
August 4, 2011
Report Date
August 4, 2011
Manufacturer
BECKMAN COULTER, INC.
Product Code
GKZ
PMA / PMN Number
K081930
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
ND, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SAMPLE COLLECTION AND STORAGE INFORMATION WERE NOT PROVIDED. THE CONTROLS WERE RUN PRIOR TO PROCESSING THE SPECIFIC SPECIMEN AND AFTER THE EVENT. ALL RESULTS WERE WITHIN THE SPECIFICATIONS. THE FLAGGING SENSITIVITY SETTINGS WERE [3303], WHERE THE BLASTS, VARIANT LYMPH, IMM NE 1, IMM NE 2, WERE ALL SET AT HIGHEST LEVEL AND IMM NE1 WAS SET TO OFF. RAW DATA ANALYSIS PROVIDED THE FOLLOWING: THE SAMPLE SHOWS A RELATIVELY SMALL AMOUNT OF NEUTROPHILS. THE NEUTROPHIL POPULATION IS TOUCHING THE LYMPH POPULATION. THE PATTERN IS SLIGHTLY ABNORMAL, BUT IT WAS NOT SIGNIFICANT ENOUGH TO TRIGGER THE BLAST FLAGGING RULES. ON (B)(4) 2011, BEC FIELD SERVICE ENGINEER COLLECTED DATA AND VERIFIED THE INSTRUMENT. THE INSTRUMENT WAS PERFORMING WITHIN THE SPECIFICATIONS. ROOT CAUSE FOR THIS EVENT IS UNKNOWN.

Description of Event or Problem · 1

A CUSTOMER REPORTED TO BECKMAN COULTER, INC. (BEC) THAT UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM GENERATED ERRONEOUS DIFFERENTIAL RESULTS. THE INSTRUMENT DID NOT GENERATE A DIFFERENTIAL SUSPECT BLAST FLAG FOR A LYMPHOMA PATIENT WITH 28% BLASTS CELLS. THE ERRONEOUS RESULTS WERE REPORTED OUT OF THE LABORATORY. MANUAL DIFFERENTIAL TEST SHOWED 28% BLASTS CELLS. CORRECTED DIFFERENTIAL REPORT WAS ISSUED BASED ON THE MANUAL TEST. THE PATIENT RESULTS ARE SHOWN. THERE WAS NO DEATH, INJURY, OR EFFECT TO PATIENT TREATMENT ASSOCIATED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL® DXH 800 COULTER® CELLULAR ANALYSIS SYSTEM COUNTER, DIFFERENTIAL CELL GKZ BECKMAN COULTER, INC. DXH 800 NA

Patients

Seq Age Sex Outcome Treatment
1